New York Factory Growth Cools in November, but Hiring Strengthens
The New York Fed’s November survey index fell to 7.8 from 25.5, while employment rose to its highest reading since June 2022.
Manufacturing activity in New York State continued to expand in November, but at a much slower pace than in October, according to the Federal Reserve Bank of New York’s latest Empire State Manufacturing Survey.
Headline index falls 18 points
The general business conditions index dropped 18 points to 7.8 in November from 25.5 in October. A positive reading indicates that activity is still expanding, although the sharp decline signals that growth has moderated.
New orders and shipments both increased modestly. The new orders index stood at 3.0, while shipments registered 8.8. Delivery times continued to lengthen and supply availability worsened, although the survey said the pace of input and selling-price increases slowed.
Employment reaches a four-year high
One brighter signal came from the labor-market measures. The employment index rose to 18.1, its highest level since June 2022, and the average-workweek index increased to 13.5. Those readings suggest manufacturers continued adding workers and hours even as overall activity cooled.
What the report means for markets
The survey is one regional snapshot, not a complete picture of the U.S. economy. Investors and policymakers will compare it with national manufacturing, inflation and employment data before drawing broader conclusions. The New York Fed also reported that firms remained optimistic about future conditions, with its future business conditions index rising to 28.9.
The November survey responses were collected between November 2 and November 9. The figures therefore describe conditions reported by participating New York manufacturers during that period, rather than a real-time measure of the entire U.S. economy.
Source
This report is based on the linked primary announcement or official data release. The newsroom has summarized the source and identified its claims; it does not claim independent eyewitness reporting.
Editorial note: This article is for news and information, not investment or medical advice. Contact the newsroom to report a correction.